Cargando…

The PROMISe to increase precision in adjuvant therapy for early breast cancer: To “Type” or to “Print”?

Detalles Bibliográficos
Autores principales:	Cardoso, Fatima, Curigliano, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964184/ https://www.ncbi.nlm.nih.gov/pubmed/29845111 http://dx.doi.org/10.1038/s41523-018-0064-8

Ejemplares similares

Postbiotics as Promising Tools for Cancer Adjuvant Therapy
por: Homayouni Rad, Aziz, et al.
Publicado: (2021)

Delivering on the promise of precision cancer medicine
por: Berger, Michael F., et al.
Publicado: (2016)

Toward precision medicine in inflammatory breast cancer
por: Viale, Giulia, et al.
Publicado: (2019)

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
por: Curigliano, Giuseppe, et al.
Publicado: (2023)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK
por: Earl, H.M., et al.
Publicado: (2021)

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer
por: Licata, Luca, et al.
Publicado: (2023)

The promise and challenges of precision medicine in dilated cardiomyopathy
por: Mason, Samantha, et al.
Publicado: (2021)

Precision medicine in early breast cancer—beginning of a successful story?
por: Eniu, A., et al.
Publicado: (2023)

Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference()
por: Gnant, Michael, et al.
Publicado: (2022)

CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner?
por: Akhade, Amol, et al.
Publicado: (2022)

Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer
por: Madureira, Maria Beatriz, et al.
Publicado: (2023)

Implementation of Precision Cancer Medicine: Progress and the Path to Realizing the Promise of Tumor Sequencing
por: Bradbury, Angela R.
Publicado: (2019)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed?
por: Morganti, S., et al.
Publicado: (2022)

Precision Medicine in Acute Kidney Injury: A Promising Future?
por: Schaub, Jennifer A., et al.
Publicado: (2019)

Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies
por: Bracci, Laura, et al.
Publicado: (2021)

Breast cancer: current state and future promise
por: Chodosh, Lewis A
Publicado: (2011)

Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment
por: Ribeiro, J., et al.
Publicado: (2013)

The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment
por: Macias, Rocio I. R., et al.
Publicado: (2023)

Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer
por: Suárez-Arroyo, Ivette J., et al.
Publicado: (2017)

Chloroquine as a promising adjuvant therapy for type 1 Diabetes Mellitus
por: de Almeida Júnior, Renato Ferreira, et al.
Publicado: (2020)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress
por: Ganz, Patricia A
Publicado: (2016)

Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021()
por: Trapani, Dario, et al.
Publicado: (2021)

Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
por: Turano, Mimmo, et al.
Publicado: (2019)

Precision Medicine for Personalized Cancer Therapy
por: Wong, Ada Hang-Heng, et al.
Publicado: (2015)

Aptamers: Promising Tools for Cancer Diagnosis and Therapy
por: Cerchia, Laura
Publicado: (2018)

Inhibiting Jak2 Ameliorates Pulmonary Hypertension: Fulfilling the Promise of Precision Medicine
por: Leopold, Jane A.
Publicado: (2021)

Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!
por: Curigliano, Giuseppe, et al.
Publicado: (2021)

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
por: Lorenzo, Giuseppe Di, et al.
Publicado: (2022)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Research Status of Systemic Adjuvant Therapy for Early Breast Cancer
por: Hu, Wenyu, et al.
Publicado: (2023)

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies
por: Morganti, Stefania, et al.
Publicado: (2023)

Breath biopsy for early detection and precision medicine in cancer
por: van der Schee, Marc, et al.
Publicado: (2018)

Adjuvant therapy for gastric cancer – has the standard changed?
por: Valle, J W
Publicado: (2001)

Bacterial therapy: a promising strategy for cancer immunotherapy
por: Wang, Yinsong
Publicado: (2023)

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
por: Arpino, Grazia, et al.
Publicado: (2015)

Hemodynamic early goal-directed therapy: Explaining the fine print
por: Goldthwaite, Zoe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4dtsdg5mrf0oho7aisrouddk6e